{"gene":"PACS1","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1998,"finding":"PACS-1 directs TGN localization of furin by binding to the protease's phosphorylated cytosolic (acidic cluster) domain; PACS-1 connects furin to the clathrin-sorting machinery (AP-1) and functions as a coat-like protein mediating endosome-to-TGN retrieval. Antisense knockdown showed that TGN localization of furin and mannose-6-phosphate receptor, but not TGN46, depends strictly on PACS-1.","method":"In vitro binding assays, in vivo localization studies, antisense knockdown, cell-free TGN retrieval assays","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — multiple orthogonal in vitro and in vivo methods, foundational study with strong controls","pmids":["9695949"],"is_preprint":false},{"year":2000,"finding":"HIV-1 Nef binds PACS-1 via its acidic cluster (EEEE) motif; this interaction is required for Nef-induced downregulation of cell-surface MHC-I and its relocalization to the TGN. A chimeric protein bearing Nef as cytoplasmic domain localizes to the TGN after internalization in an acidic-cluster- and PACS-1-dependent manner.","method":"Co-immunoprecipitation, dominant-negative PACS-1 expression, chimeric protein localization assays, confocal microscopy","journal":"Nature cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal interaction validated by multiple approaches, replicated by subsequent studies","pmids":["10707087"],"is_preprint":false},{"year":2001,"finding":"PACS-1 associates with adaptor complexes AP-1 and AP-3, but not AP-2, forming a ternary complex with furin and AP-1. A short sequence in PACS-1 mediates AP-1 binding; mutation of this motif creates a dominant-negative that mislocalizes furin and mannose-6-phosphate receptor from the TGN and inhibits Nef-mediated MHC-I downregulation.","method":"Co-immunoprecipitation, dominant-negative mutagenesis, subcellular localization assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal Co-IP, domain mutagenesis, functional rescue experiments","pmids":["11331585"],"is_preprint":false},{"year":2002,"finding":"Nef and PACS-1 cooperate to usurp the ARF6 endocytic pathway in a PI3K-dependent manner to downregulate cell-surface MHC-I to the TGN. Three Nef motifs act hierarchically: acidic cluster 62EEEE65 controls PACS-1-dependent TGN sorting, 72PXXP75 controls ARF6 activation, and M20 sequesters internalized MHC-I to the TGN.","method":"Dominant-negative expression, ARF6 activation assays, PI3K inhibition, mutagenesis of Nef motifs, subcellular localization","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — mechanistic epistasis with multiple mutants and orthogonal pathway inhibitors","pmids":["12526811"],"is_preprint":false},{"year":2003,"finding":"PACS-1 interacts with the acidic cluster in the cytoplasmic domain of HCMV glycoprotein B (gB) and is required for normal TGN localization of gB. Inhibition of PACS-1 function in infected cells decreases HCMV titer; overexpression of functional PACS-1 increases titer.","method":"Co-immunoprecipitation, dominant-negative PACS-1 expression, viral titer assays, subcellular localization","journal":"Journal of virology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, dominant-negative, functional titer readout, single lab with multiple methods","pmids":["14512558"],"is_preprint":false},{"year":2003,"finding":"PACS-1 mediates phosphorylation-dependent recruitment to VAMP4: CK2 phosphorylation of Ser30 on VAMP4 promotes PACS-1 binding and enhances AP-1 association with VAMP4. Dominant-negative PACS-1 causes mislocalization of VAMP4 in the regulated secretory pathway.","method":"Co-immunoprecipitation, mutagenesis of phosphorylation site, dominant-negative PACS-1, subcellular localization in AtT20 cells","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 / Moderate — phosphorylation-site mutagenesis, dominant-negative, Co-IP, functional localization readout","pmids":["14608369"],"is_preprint":false},{"year":2005,"finding":"CK2-mediated phosphorylation of three critical serine residues within an acidic cluster of nephrocystin promotes PACS-1 binding; this interaction is required for colocalization of nephrocystin with PACS-1 at the base of cilia. CK2 inhibition abolishes the interaction and causes loss of correct nephrocystin targeting.","method":"Co-immunoprecipitation, CK2 inhibition, mutagenesis of nephrocystin phosphorylation sites, immunofluorescence colocalization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — phosphorylation-site mutagenesis, kinase inhibition, Co-IP, functional localization readout","pmids":["16308564"],"is_preprint":false},{"year":2006,"finding":"PACS-1 forms a trimeric complex with GGA3 and CK2 to control CI-MPR sorting. CK2 bound to PACS-1 phosphorylates GGA3, releasing it from CI-MPR, and also phosphorylates PACS-1 Ser278, promoting PACS-1 binding to CI-MPR for retrieval to the TGN. PACS-1 thus links GGA3 to CK2 in a phosphorylation cascade coordinating opposing sorting steps.","method":"Co-immunoprecipitation, in vitro kinase assays, mutagenesis of PACS-1 Ser278, GGA3 phosphorylation assays, subcellular localization","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — in vitro kinase assay, reciprocal Co-IP, site-directed mutagenesis, multiple orthogonal methods","pmids":["16977309"],"is_preprint":false},{"year":2007,"finding":"PACS-1 knockdown (siRNA) has no effect on Nef-induced HLA-A2 downregulation or on localization of other acidic-cluster-containing proteins in HeLa cells, in contrast to AP-1 and clathrin knockdown which do inhibit Nef activity. Immuno-EM shows Nef reroutes MHC-I to endosomes rather than the TGN.","method":"siRNA knockdown of PACS-1, AP-1, clathrin; flow cytometry; immuno-electron microscopy","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — negative finding for PACS-1 role in Nef/MHC-I in HeLa cells specifically; single lab contradicting earlier work","pmids":["17581864"],"is_preprint":false},{"year":2007,"finding":"SorLA TGN localization and its activity in retaining APP requires functional interaction with PACS-1 and GGA adaptors. Aberrant targeting of sorLA to the recycling compartment or plasma membrane causes faulty APP trafficking and increased amyloidogenic processing.","method":"Co-immunoprecipitation, dominant-negative adaptor expression, subcellular localization assays, APP processing readout","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP plus functional APP processing readout, single lab","pmids":["17855360"],"is_preprint":false},{"year":2009,"finding":"PACS-1 mediates CK2 phosphorylation-dependent ciliary trafficking of the olfactory CNG channel. CNGB1b contains PACS-1 binding sites phosphorylated by CK2; PACS-1 interacts with the CNG channel complex, and adenoviral expression of dominant-negative PACS-1 or CK2 inhibition causes CNG channel loss from cilia and olfactory dysfunction.","method":"Co-immunoprecipitation, dominant-negative PACS-1 adenoviral expression, CK2 inhibition, electrophysiology (olfactory function), immunofluorescence","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — dominant-negative, Co-IP, CK2 inhibition, functional electrophysiological readout","pmids":["19710307"],"is_preprint":false},{"year":2012,"finding":"A bipartite site on Nef (EEEE65 acidic cluster + W113 in core domain) interacts with a cargo subsite on PACS-1 and PACS-2. This interaction occurs on Rab5- and Rab7-positive endosomes (demonstrated by bimolecular fluorescence complementation). Disruption of the Nef–PACS interaction prevents Nef-induced MHC-I downregulation in PBMCs.","method":"Bimolecular fluorescence complementation, mutagenesis of Nef and PACS interaction sites, Co-immunoprecipitation, MHC-I downregulation assay in PBMCs","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods including BiFC for in-cell interaction mapping, functional rescue","pmids":["22496420"],"is_preprint":false},{"year":2012,"finding":"The PACS1 p.Arg203Trp de novo missense mutation causes PACS-1 to form cytoplasmic aggregates with increased protein stability in vitro. Mutant PACS1 shows impaired binding to a TRPV4 isoform but not the full-length protein. Expression of mutant PACS1 mRNA in zebrafish disrupts cranial (SOX10-positive) neural-crest cell specification and migration, causing craniofacial defects in a dominant-negative fashion.","method":"In vitro protein expression/aggregation assays, co-immunoprecipitation with TRPV4 isoforms, zebrafish mRNA injection with SOX10 reporter imaging","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — in vitro protein assays, binding assay, in vivo zebrafish model with lineage tracing","pmids":["23159249"],"is_preprint":false},{"year":2013,"finding":"PACS1 interaction with SORLA is required for SORLA/APP complex sorting to the TGN in neurons. PACS1 knockdown or a PACS1-binding-defective SORLA mutant in transgenic mice increases APP processing and Aβ production. PACS1 loss also impairs CI-MPR and cathepsin B expression, affecting Aβ degradation independently of SORLA.","method":"siRNA knockdown in neuronal cell lines, transgenic mice with PACS1-binding-defective SORLA mutant, APP processing/Aβ ELISA, CI-MPR and cathepsin B Western blot","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knockdown plus transgenic mouse model, multiple functional readouts","pmids":["24001769"],"is_preprint":false},{"year":2017,"finding":"PACS-1 protein accumulates in the nucleus during cell cycle progression and interacts with HDAC2 and HDAC3 to regulate chromatin dynamics by maintaining histone acetylation status. PACS-1 knockdown leads to proteasome-mediated degradation of HDAC2/HDAC3, elevated H3K9 and H4K16 acetylation, and increased replication stress-induced DNA damage and genomic instability.","method":"Subcellular fractionation/nuclear accumulation during cell cycle, Co-immunoprecipitation of PACS-1 with HDAC2/HDAC3, siRNA knockdown, histone acetylation Western blot, DNA damage assays","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, siRNA, multiple biochemical readouts, single lab","pmids":["31988453"],"is_preprint":false},{"year":2017,"finding":"Par3 facilitates BACE1 retrograde endosome-to-TGN trafficking through aPKC-mediated phosphorylation of BACE1 Ser498, which promotes BACE1 interaction with PACS-1; disruption of this phosphorylation in AD brains correlates with reduced retrograde transport.","method":"Co-immunoprecipitation, site-directed mutagenesis of BACE1 Ser498, subcellular localization assays, human AD brain phosphorylation analysis","journal":"Neurobiology of aging","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, phospho-site mutagenesis, localization assay, single lab","pmids":["28946017"],"is_preprint":false},{"year":2017,"finding":"PCAF and ADA3 transcriptionally regulate PACS1 expression. Cells with decreased PACS1 expression fail to undergo mitochondrial apoptosis (cytochrome c release) in response to granzyme B, staurosporine, UV, and etoposide due to perturbed BAX and BAK oligomerization, placing PACS1 as a required component for intrinsic apoptosis upstream of BAX/BAK oligomerization.","method":"siRNA knockdown of PACS1, cytochrome c release assay, BAX/BAK oligomerization native gel assay, cell death assays with multiple stimuli","journal":"Cell death and differentiation","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — loss-of-function with specific mechanistic readout (BAX/BAK oligomerization), single lab","pmids":["28060382"],"is_preprint":false},{"year":2019,"finding":"PACS1 shuttles between nucleus and cytoplasm, associates with HIV-1 Rev and CRM1, and contributes to nuclear export of unspliced viral RNA. Overexpression of PACS1 increases nuclear export of unspliced viral RNA and p24 in HIV-1-infected CD4+ T cells; siRNA depletion reduces this activity.","method":"Nuclear/cytoplasmic fractionation, Co-immunoprecipitation with Rev and CRM1, siRNA knockdown and overexpression, viral RNA export assays, p24 ELISA","journal":"Virology","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, fractionation, functional overexpression/knockdown in infected cells, single lab","pmids":["31759187"],"is_preprint":false},{"year":2018,"finding":"PACS-1 and AP-1 are required for targeting of POMC (pro-ACTH) to dense core secretory granules (DCSGs). Knockdown of PACS-1 or AP-1 causes POMC to be secreted into the extracellular milieu rather than packaged into DCSGs.","method":"siRNA knockdown, subcellular fractionation, secretion assay","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — siRNA knockdown with defined secretion phenotype, single lab","pmids":["30458990"],"is_preprint":false},{"year":2020,"finding":"PACS-1 nuclear localization occurs at G1-S phase of the cell cycle (detected by immunofluorescence post-serum starvation release). Loss of PACS-1 via siRNA increases nuclear γH2AX and Lys382-p53 acetylation, indicating DNA damage response; PACS-1 re-expression reverses these effects.","method":"siRNA knockdown, serum starvation/release cell cycle synchronization, immunofluorescence for γH2AX and p53 acetylation, flow cytometry","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — loss- and gain-of-function with biochemical readouts, single lab","pmids":["33028635"],"is_preprint":false},{"year":2021,"finding":"Pacs1 and Wdr37 form a complex required for normal ER Ca2+ handling in lymphocytes. Pacs1 deletion causes peripheral lymphopenia linked to blunted Ca2+ release from ER after antigen receptor stimulation, diminished IP3 receptor expression, and increased ER and oxidative stress. Mature Pacs1-/- B cells lose quiescence spontaneously, and Pacs1-Wdr37 disruption suppresses lymphoproliferative disease in mouse models.","method":"Knockout mouse (Pacs1-/-), Ca2+ imaging, forward genetic screening, IP3 receptor expression analysis, lymphocyte proliferation assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Moderate — knockout mouse with multiple functional readouts, Ca2+ imaging, discovery by forward genetic screen","pmids":["33630350"],"is_preprint":false},{"year":2021,"finding":"PACS-1 nuclear-cytoplasmic trafficking is mediated by importin alpha 5 (nuclear import) and exportin 1/CRM1 (nuclear export), defined by an NLS (residues 311–318) and NES3 (residues 366–375). PACS-1 forms a complex with the RNA-binding protein PTBP1 in both nucleus and cytosol; mutation of the NLS or NES3 alters localization of this PACS-1/PTBP1 complex.","method":"Mutagenesis of NLS and NES, importin/exportin interaction assays, Co-immunoprecipitation with PTBP1, subcellular localization","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — site-directed mutagenesis of transport signals with functional localization readout, Co-IP, single lab","pmids":["34822171"],"is_preprint":false},{"year":2023,"finding":"PACS1 p.R203W mutation increases PACS1 interaction with HDAC6, aberrantly potentiating its deacetylase activity, reducing acetylation of α-tubulin and cortactin, causing Golgi ribbon fragmentation and overpopulation of dendrites. Dendrites show varicosities, diminished spine density, and fewer functional synapses. PACS1- or HDAC6-targeting antisense oligonucleotides, or HDAC6 inhibitors, restore neuronal structure and synaptic transmission in PACS1 syndrome mice and patient NPCs.","method":"Co-immunoprecipitation (patient cells and mouse), HDAC6 activity assay, α-tubulin/cortactin acetylation Western blot, Golgi morphology imaging, spine density/synapse electrophysiology, ASO treatment in mice and patient iPSC-derived NPCs","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro activity assay, patient cells, mouse model, multiple orthogonal methods, therapeutic rescue","pmids":["37848409"],"is_preprint":false},{"year":2024,"finding":"PACS-1 interacts with TRPC3 calcium channel and ESyt1 ER-plasma membrane tethering protein, promotes TRPC3–ESyt1 interactions, and regulates their plasma membrane localization. PACS-1 is required for proper store-operated calcium entry (SOCE) response, and ESyt1 regulates ACTH secretion through a mechanism dependent on PACS-1.","method":"Co-immunoprecipitation, plasma membrane localization assays, SOCE calcium imaging, ACTH secretion assay with knockdown","journal":"ACS omega","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, functional calcium and hormone secretion readouts, single lab","pmids":["39157130"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structure of the Pacs1–Wdr37 complex shows Pacs1 binds Wdr37 through a conserved interface within its furin-binding region (FBR). This interaction stabilizes Wdr37 and is critical for expression of both proteins. The pathogenic R203W mutation lies on a solvent-exposed surface of the FBR and does not disrupt complex formation. Structural homology of the FBR to synaptotagmin C2 domains reveals Pacs1 can bind negatively charged phospholipids through a positively charged cleft.","method":"Cryo-electron microscopy structure determination, biochemical stability assays, phospholipid binding assays, expression analysis of R203W mutant","journal":"bioRxiv","confidence":"High","confidence_rationale":"Tier 1 / Moderate — cryo-EM structure with functional validation, structural homology analysis, preprint","pmids":["41279321"],"is_preprint":true},{"year":2026,"finding":"PACS1 interacts with cytoplasmic dynein-1 heavy chain (DHC1) and is required for furin localization at the TGN. PACS1R203W induces a dynein loss-of-function phenotype: PACS1R203W-HDAC6 recruits adaptor BICD2, forming a complex that disperses the Golgi. Cargo motility assays show PACS1R203W reduces dynein initiation frequency and velocity; these defects are rescued by HDAC6 inhibition or Lis1 expression.","method":"Co-immunoprecipitation of PACS1 with DHC1 and BICD2, cargo motility assays, HDAC6 inhibition, Lis1 overexpression rescue, Golgi morphology imaging","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, cargo motility assays, genetic/pharmacological rescue, multiple orthogonal methods","pmids":["41888583"],"is_preprint":false},{"year":2026,"finding":"NMR solution structure of the PACS-1 FBR (residues 101–273) reveals that the PACS-1/HDAC6 interaction is regulated by an intramolecular mechanism: the central unstructured region folds back across the FBR and engages a positively charged extended loop. The R203W substitution, located in this loop, disrupts this regulatory intramolecular interaction and in vitro promotes aberrant protein-protein interactions.","method":"NMR structure determination of chimeric FBR, in vitro binding assays with HDAC6, NMR-based interaction mapping, R203W mutagenesis","journal":"The FEBS journal","confidence":"High","confidence_rationale":"Tier 1 / Moderate — NMR structure with in vitro functional validation and mutagenesis","pmids":["41858172"],"is_preprint":false}],"current_model":"PACS-1 is a multifunctional cytosolic adaptor protein whose furin-binding region (FBR) binds phosphorylated acidic cluster motifs on membrane cargo proteins (furin, CI-MPR, BACE1, VAMP4, HCMV gB, HIV-1 Nef, nephrocystin, CNG channel subunit, SorLA) and connects them to clathrin adaptor complexes (AP-1, AP-3) and CK2 to mediate endosome-to-TGN retrieval and ciliary targeting; it forms a structurally defined complex with WDR37 through its FBR (cryo-EM structure), is required for ER Ca²⁺ homeostasis and lymphocyte quiescence, regulates the intrinsic apoptosis pathway via BAX/BAK oligomerization, functions in the nucleus by interacting with HDAC2/HDAC3 to maintain chromatin integrity, and the disease-causing R203W substitution disrupts an intramolecular regulatory interaction in the FBR, aberrantly enhancing HDAC6 deacetylase activity and BICD2-mediated dynein dysfunction to cause Golgi fragmentation and synaptic deficits in neurons."},"narrative":{"mechanistic_narrative":"PACS-1 is a multifunctional cytosolic sorting adaptor that controls the trans-Golgi network (TGN) localization of membrane cargo bearing phosphorylated acidic-cluster motifs [PMID:9695949]. Its furin-binding region (FBR) recognizes acidic clusters that have been phosphorylated by CK2 on cargo such as furin, the mannose-6-phosphate receptor, VAMP4, nephrocystin, the olfactory CNG channel, SorLA/SORLA, and HCMV glycoprotein B, and it connects these cargo to the clathrin adaptor complexes AP-1 and AP-3 to drive endosome-to-TGN retrieval and ciliary or secretory-granule targeting [PMID:9695949, PMID:11331585, PMID:14608369, PMID:16308564, PMID:19710307, PMID:30458990]. PACS-1 acts as a node in CK2-based phosphorylation cascades, coordinating opposing sorting events by both binding CK2 and being phosphorylated by it (e.g. at Ser278 to control CI-MPR retrieval) [PMID:16977309]. Through these trafficking functions PACS-1 is exploited by pathogens — HIV-1 Nef engages a cargo subsite on PACS-1 through its acidic cluster to reroute MHC-I [PMID:10707087, PMID:22496420] — and modulates neuronal SORLA/APP sorting to limit amyloidogenic processing [PMID:17855360, PMID:24001769]. Beyond the secretory pathway, PACS-1 shuttles between nucleus and cytoplasm via importin-α5 and CRM1 [PMID:34822171], accumulates in the nucleus at G1-S where it stabilizes HDAC2/HDAC3 to maintain histone acetylation and genomic integrity [PMID:31988453, PMID:33028635], is required upstream of BAX/BAK oligomerization for intrinsic apoptosis [PMID:28060382], and forms a complex with WDR37 needed for ER Ca²⁺ homeostasis and lymphocyte quiescence [PMID:33630350, PMID:41279321]. The de novo p.R203W substitution in the FBR causes PACS1 syndrome: it disrupts an intramolecular regulatory interaction within the FBR [PMID:41858172], aberrantly enhancing HDAC6 deacetylase activity to reduce α-tubulin/cortactin acetylation and fragment the Golgi [PMID:37848409], and promoting a BICD2/dynein loss-of-function that disperses the Golgi and impairs cargo motility, with HDAC6 inhibition or Lis1 rescuing the defects [PMID:41888583].","teleology":[{"year":1998,"claim":"Established the founding function of PACS-1: how cargo such as furin returns to the TGN was unknown, and PACS-1 was identified as the adaptor that reads phosphorylated acidic clusters and links cargo to clathrin sorting machinery.","evidence":"In vitro binding, in vivo localization, antisense knockdown, and cell-free TGN retrieval assays for furin and M6PR","pmids":["9695949"],"confidence":"High","gaps":["Did not define which clathrin adaptor subunit PACS-1 contacts","Did not resolve the cargo-recognition domain structurally"]},{"year":2001,"claim":"Resolved how PACS-1 couples cargo to coats by mapping its association with AP-1 and AP-3 (but not AP-2) and showing a ternary furin–PACS-1–AP-1 complex, establishing the adaptor-bridging logic.","evidence":"Co-IP and dominant-negative mutagenesis of the AP-1-binding motif with cargo mislocalization readouts","pmids":["11331585"],"confidence":"High","gaps":["Did not establish stoichiometry or the structural basis of AP-1 engagement"]},{"year":2006,"claim":"Showed PACS-1 is not a passive adaptor but a CK2-organized phosphorylation hub, both delivering CK2 to phosphorylate GGA3 and being phosphorylated at Ser278 to coordinate opposing CI-MPR sorting steps.","evidence":"In vitro kinase assays, reciprocal Co-IP, and Ser278 mutagenesis with localization readouts","pmids":["16977309"],"confidence":"High","gaps":["Did not generalize the cascade to other cargo","Did not define CK2-binding interface on PACS-1"]},{"year":2009,"claim":"Extended PACS-1 cargo-sorting beyond the TGN to ciliary and regulated-secretory targeting, establishing it as a general CK2-phosphorylation-dependent adaptor for acidic-cluster cargo.","evidence":"Co-IP, dominant-negative PACS-1, CK2 inhibition, and electrophysiology for CNG channel ciliary trafficking; later siRNA/secretion assays for POMC granule packaging","pmids":["19710307","30458990"],"confidence":"High","gaps":["Did not establish whether ciliary and granule targeting use the same adaptor partners as TGN retrieval"]},{"year":2012,"claim":"Mapped the molecular basis of pathogen hijacking by defining a bipartite Nef site engaging a cargo subsite on PACS-1/PACS-2 on Rab5/Rab7 endosomes, refining where and how Nef downregulates MHC-I.","evidence":"Bimolecular fluorescence complementation, interaction-site mutagenesis, and MHC-I downregulation assays in PBMCs","pmids":["10707087","22496420"],"confidence":"High","gaps":["A negative siRNA study in HeLa cells (idx 8) indicates the requirement for PACS-1 in Nef/MHC-I is cell-type dependent and not fully reconciled"]},{"year":2013,"claim":"Connected PACS-1 trafficking to disease-relevant biology by showing it sorts SORLA/APP to the TGN in neurons, controlling amyloidogenic processing and Aβ degradation.","evidence":"siRNA knockdown, transgenic mice with a PACS1-binding-defective SORLA, APP/Aβ ELISA and CI-MPR/cathepsin B blots","pmids":["17855360","24001769"],"confidence":"High","gaps":["Did not establish a causal role in human Alzheimer's disease"]},{"year":2017,"claim":"Revealed unexpected nuclear and apoptotic functions for PACS-1: it stabilizes HDAC2/HDAC3 to maintain chromatin acetylation and genomic integrity, and is required upstream of BAX/BAK oligomerization for intrinsic apoptosis.","evidence":"Subcellular fractionation, Co-IP with HDAC2/3, siRNA, histone-acetylation and DNA-damage assays; separate BAX/BAK oligomerization native gels with multiple apoptotic stimuli","pmids":["31988453","28060382","33028635"],"confidence":"Medium","gaps":["Single-lab findings without reciprocal structural validation","Mechanism linking cytosolic sorting role to nuclear HDAC stabilization unresolved","How PACS-1 acts upstream of BAX/BAK is undefined"]},{"year":2021,"claim":"Identified the PACS-1–WDR37 complex as a regulator of ER Ca²⁺ handling and lymphocyte quiescence, and defined the nucleocytoplasmic transport machinery (importin-α5, CRM1) governing PACS-1 shuttling.","evidence":"Pacs1-/- knockout mouse with Ca²⁺ imaging and forward genetics; NLS/NES mutagenesis and Co-IP with PTBP1","pmids":["33630350","34822171"],"confidence":"High","gaps":["Did not establish the molecular link between PACS-1/WDR37 and IP3 receptor expression","Functional role of the PACS-1/PTBP1 complex undefined"]},{"year":2023,"claim":"Defined the mechanism of PACS1 syndrome: the de novo R203W substitution aberrantly enhances HDAC6 deacetylase activity, reducing α-tubulin/cortactin acetylation and fragmenting the Golgi, with HDAC6 inhibition or ASOs rescuing neuronal structure.","evidence":"Co-IP from patient cells and mice, HDAC6 activity assays, acetylation blots, synapse electrophysiology, and ASO therapy in mice and patient NPCs","pmids":["23159249","37848409"],"confidence":"High","gaps":["Did not resolve how R203W structurally enables aberrant HDAC6 binding"]},{"year":2026,"claim":"Provided the structural and motor-pathway mechanism for the R203W gain-of-function: an intramolecular FBR regulatory interaction is disrupted by R203W, and the mutant couples HDAC6 to BICD2/dynein causing dynein loss-of-function and Golgi dispersal.","evidence":"NMR solution structure of the FBR with HDAC6 binding assays; cryo-EM of the Pacs1–Wdr37 complex; Co-IP with DHC1/BICD2, cargo motility assays, HDAC6 inhibition and Lis1 rescue","pmids":["41858172","41888583","41279321"],"confidence":"High","gaps":["Cryo-EM/phospholipid-binding inference from synaptotagmin homology is from a preprint","How the FBR intramolecular state is normally regulated in cells is undefined"]},{"year":null,"claim":"How PACS-1's diverse functions — cytosolic cargo sorting, nuclear HDAC stabilization, apoptosis, and ER/store-operated Ca²⁺ regulation — are coordinated by one protein, and which are physiologically dominant, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model linking cytosolic and nuclear pools","Relative contribution of trafficking vs HDAC vs dynein defects to PACS1 syndrome unsettled","Structure of full-length PACS-1 with bound cargo unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,2,5,7]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[24]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[22,26]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[14]}],"localization":[{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[0,21]},{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[0,22,25]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[11]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[14,19,21]}],"pathway":[{"term_id":"R-HSA-5653656","term_label":"Vesicle-mediated transport","supporting_discovery_ids":[0,2,5,7]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,10,18]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[14,19]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[16]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[20]}],"complexes":["PACS-1–WDR37 complex","furin–PACS-1–AP-1 ternary complex","PACS-1–GGA3–CK2 trimeric complex"],"partners":["WDR37","AP-1","AP-3","GGA3","HDAC2","HDAC3","HDAC6","BICD2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q6VY07","full_name":"Phosphofurin acidic cluster sorting protein 1","aliases":[],"length_aa":963,"mass_kda":104.9,"function":"Coat protein that is involved in the localization of trans-Golgi network (TGN) membrane proteins that contain acidic cluster sorting motifs. Controls the endosome-to-Golgi trafficking of furin and mannose-6-phosphate receptor by connecting the acidic-cluster-containing cytoplasmic domain of these molecules with the adapter-protein complex-1 (AP-1) of endosomal clathrin-coated membrane pits. Involved in HIV-1 nef-mediated removal of MHC-I from the cell surface to the TGN. Required for normal ER Ca2+ handling in lymphocytes. Together with WDR37, it plays an essential role in lymphocyte development, quiescence and survival. Required for stabilizing peripheral lymphocyte populations (By similarity)","subcellular_location":"Golgi apparatus, trans-Golgi network","url":"https://www.uniprot.org/uniprotkb/Q6VY07/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PACS1","classification":"Not Classified","n_dependent_lines":73,"n_total_lines":1208,"dependency_fraction":0.060430463576158944},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PACS1","total_profiled":1310},"omim":[{"mim_id":"615009","title":"SCHUURS-HOEIJMAKERS SYNDROME; SHMS","url":"https://www.omim.org/entry/615009"},{"mim_id":"610423","title":"PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 2; PACS2","url":"https://www.omim.org/entry/610423"},{"mim_id":"607492","title":"PHOSPHOFURIN ACIDIC CLUSTER SORTING PROTEIN 1; PACS1","url":"https://www.omim.org/entry/607492"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/PACS1"},"hgnc":{"alias_symbol":["FLJ10209","KIAA1175"],"prev_symbol":[]},"alphafold":{"accession":"Q6VY07","domains":[{"cath_id":"2.60.40.150","chopping":"98-256","consensus_level":"high","plddt":82.2693,"start":98,"end":256},{"cath_id":"3.40.50","chopping":"545-716","consensus_level":"high","plddt":92.6819,"start":545,"end":716},{"cath_id":"2.60.200.40","chopping":"726-757_817-829_845-882_900-944","consensus_level":"medium","plddt":84.7002,"start":726,"end":944}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6VY07","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6VY07-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6VY07-F1-predicted_aligned_error_v6.png","plddt_mean":64.81},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PACS1","jax_strain_url":"https://www.jax.org/strain/search?query=PACS1"},"sequence":{"accession":"Q6VY07","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6VY07.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6VY07/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6VY07"}},"corpus_meta":[{"pmid":"9695949","id":"PMC_9695949","title":"PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization.","date":"1998","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/9695949","citation_count":331,"is_preprint":false},{"pmid":"10707087","id":"PMC_10707087","title":"HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes.","date":"2000","source":"Nature cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/10707087","citation_count":252,"is_preprint":false},{"pmid":"12526811","id":"PMC_12526811","title":"HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/12526811","citation_count":249,"is_preprint":false},{"pmid":"11331585","id":"PMC_11331585","title":"PACS-1 binding to adaptors is required for acidic cluster motif-mediated protein traffic.","date":"2001","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/11331585","citation_count":164,"is_preprint":false},{"pmid":"17855360","id":"PMC_17855360","title":"SorLA/LR11 regulates processing of amyloid precursor protein via interaction with adaptors GGA and PACS-1.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17855360","citation_count":154,"is_preprint":false},{"pmid":"23159249","id":"PMC_23159249","title":"Recurrent de novo mutations in PACS1 cause defective cranial-neural-crest migration and define a recognizable intellectual-disability syndrome.","date":"2012","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23159249","citation_count":105,"is_preprint":false},{"pmid":"17581864","id":"PMC_17581864","title":"HIV-1 Nef-induced down-regulation of MHC class I requires AP-1 and clathrin but not PACS-1 and is impeded by AP-2.","date":"2007","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/17581864","citation_count":87,"is_preprint":false},{"pmid":"16977309","id":"PMC_16977309","title":"A PACS-1, GGA3 and CK2 complex regulates CI-MPR trafficking.","date":"2006","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16977309","citation_count":78,"is_preprint":false},{"pmid":"16308564","id":"PMC_16308564","title":"Phosphorylation by casein kinase 2 induces PACS-1 binding of nephrocystin and targeting to cilia.","date":"2005","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/16308564","citation_count":75,"is_preprint":false},{"pmid":"14512558","id":"PMC_14512558","title":"Role of PACS-1 in trafficking of human cytomegalovirus glycoprotein B and virus production.","date":"2003","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/14512558","citation_count":59,"is_preprint":false},{"pmid":"22496420","id":"PMC_22496420","title":"An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22496420","citation_count":58,"is_preprint":false},{"pmid":"14608369","id":"PMC_14608369","title":"AP-1 recruitment to VAMP4 is modulated by phosphorylation-dependent binding of PACS-1.","date":"2003","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/14608369","citation_count":55,"is_preprint":false},{"pmid":"28060382","id":"PMC_28060382","title":"Epigenetic control of mitochondrial cell death through PACS1-mediated regulation of BAX/BAK oligomerization.","date":"2017","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/28060382","citation_count":54,"is_preprint":false},{"pmid":"26842493","id":"PMC_26842493","title":"Clinical delineation of the PACS1-related syndrome--Report on 19 patients.","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/26842493","citation_count":49,"is_preprint":false},{"pmid":"24001769","id":"PMC_24001769","title":"SORLA-dependent and -independent functions for PACS1 in control of amyloidogenic processes.","date":"2013","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/24001769","citation_count":30,"is_preprint":false},{"pmid":"19710307","id":"PMC_19710307","title":"PACS-1 mediates phosphorylation-dependent ciliary trafficking of the cyclic-nucleotide-gated channel in olfactory sensory neurons.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19710307","citation_count":30,"is_preprint":false},{"pmid":"33028635","id":"PMC_33028635","title":"Dysregulation of hsa-miR-34a and hsa-miR-449a leads to overexpression of PACS-1 and loss of DNA damage response (DDR) in cervical cancer.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33028635","citation_count":28,"is_preprint":false},{"pmid":"33630350","id":"PMC_33630350","title":"Calcium flux control by Pacs1-Wdr37 promotes lymphocyte quiescence and lymphoproliferative diseases.","date":"2021","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/33630350","citation_count":26,"is_preprint":false},{"pmid":"28946017","id":"PMC_28946017","title":"Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1.","date":"2017","source":"Neurobiology of aging","url":"https://pubmed.ncbi.nlm.nih.gov/28946017","citation_count":25,"is_preprint":false},{"pmid":"31988453","id":"PMC_31988453","title":"The multifunctional protein PACS-1 is required for HDAC2- and HDAC3-dependent chromatin maturation and genomic stability.","date":"2020","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/31988453","citation_count":23,"is_preprint":false},{"pmid":"34068396","id":"PMC_34068396","title":"Schuurs-Hoeijmakers Syndrome (PACS1 Neurodevelopmental Disorder): Seven Novel Patients and a Review.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/34068396","citation_count":20,"is_preprint":false},{"pmid":"28975623","id":"PMC_28975623","title":"A novel missense mutation affecting the same amino acid as the recurrent PACS1 mutation in Schuurs-Hoeijmakers syndrome.","date":"2017","source":"Clinical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28975623","citation_count":20,"is_preprint":false},{"pmid":"34594577","id":"PMC_34594577","title":"miR-485-5p alleviates Alzheimer's disease progression by targeting PACS1.","date":"2021","source":"Translational neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34594577","citation_count":19,"is_preprint":false},{"pmid":"37848409","id":"PMC_37848409","title":"Neural deficits in a mouse model of PACS1 syndrome are corrected with PACS1- or HDAC6-targeting therapy.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37848409","citation_count":17,"is_preprint":false},{"pmid":"38280846","id":"PMC_38280846","title":"iPSC-derived models of PACS1 syndrome reveal transcriptional and functional deficits in neuron activity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38280846","citation_count":15,"is_preprint":false},{"pmid":"31759187","id":"PMC_31759187","title":"PACS1 is an HIV-1 cofactor that functions in Rev-mediated nuclear export of viral RNA.","date":"2019","source":"Virology","url":"https://pubmed.ncbi.nlm.nih.gov/31759187","citation_count":15,"is_preprint":false},{"pmid":"34517877","id":"PMC_34517877","title":"PACS1-Neurodevelopmental disorder: clinical features and trial readiness.","date":"2021","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/34517877","citation_count":14,"is_preprint":false},{"pmid":"36077045","id":"PMC_36077045","title":"Molecular Basis of the Schuurs-Hoeijmakers Syndrome: What We Know about the Gene and the PACS-1 Protein and Novel Therapeutic Approaches.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/36077045","citation_count":14,"is_preprint":false},{"pmid":"32903913","id":"PMC_32903913","title":"Renpenning Syndrome in a Turkish Patient: de novo Variant c.607C>T in PACS1 and Hypogammaglobulinemia Phenotype.","date":"2020","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/32903913","citation_count":14,"is_preprint":false},{"pmid":"29550517","id":"PMC_29550517","title":"Ocular manifestations of PACS1 mutation.","date":"2018","source":"Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus","url":"https://pubmed.ncbi.nlm.nih.gov/29550517","citation_count":12,"is_preprint":false},{"pmid":"33369122","id":"PMC_33369122","title":"Coloboma may be a shared feature in a spectrum of disorders caused by mutations in the WDR37-PACS1-PACS2 axis.","date":"2020","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/33369122","citation_count":11,"is_preprint":false},{"pmid":"34822171","id":"PMC_34822171","title":"PACS-1 contains distinct motifs for nuclear-cytoplasmic transport and interacts with the RNA-binding protein PTBP1 in the nucleus and cytosol.","date":"2021","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/34822171","citation_count":8,"is_preprint":false},{"pmid":"30458990","id":"PMC_30458990","title":"PACS-1 and adaptor protein-1 mediate ACTH trafficking to the regulated secretory pathway.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30458990","citation_count":5,"is_preprint":false},{"pmid":"37141437","id":"PMC_37141437","title":"Do PACS1 variants impeding adaptor protein binding predispose to syndromic intellectual disability?","date":"2023","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/37141437","citation_count":4,"is_preprint":false},{"pmid":"39031646","id":"PMC_39031646","title":"PACS-1 variant protein is aberrantly localized in Caenorhabditis elegans model of PACS1/PACS2 syndromes.","date":"2024","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39031646","citation_count":4,"is_preprint":false},{"pmid":"37064331","id":"PMC_37064331","title":"First Report of Mexican Patients with PACS1-Related Neurodevelopmental Disorder and Review of the PACS1-, PACS2-, and WDR37-Related Ophthalmological Manifestations.","date":"2022","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/37064331","citation_count":2,"is_preprint":false},{"pmid":"40004556","id":"PMC_40004556","title":"Expanding the Clinical Spectrum Associated with the Recurrent Arg203Trp Variant in PACS1: An Italian Cohort Study.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40004556","citation_count":2,"is_preprint":false},{"pmid":"36415352","id":"PMC_36415352","title":"A Novel PACS1 Variant Associated With Schuurs-Hoeijmakers Syndrome Phenotype in an Indigenous Descendant in Brazil: A Case Report.","date":"2022","source":"Cureus","url":"https://pubmed.ncbi.nlm.nih.gov/36415352","citation_count":2,"is_preprint":false},{"pmid":"39157130","id":"PMC_39157130","title":"PACS-1 Interacts with TRPC3 and ESyt1 to Mediate Protein Trafficking while Promoting SOCE and Cooperatively Regulating Hormone Secretion.","date":"2024","source":"ACS omega","url":"https://pubmed.ncbi.nlm.nih.gov/39157130","citation_count":2,"is_preprint":false},{"pmid":"36747781","id":"PMC_36747781","title":"RNA-targeted therapy corrects neuronal deficits in PACS1 syndrome mice.","date":"2023","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/36747781","citation_count":1,"is_preprint":false},{"pmid":"37218682","id":"PMC_37218682","title":"A case report of retinal dystrophy in patients with PACS1 syndrome.","date":"2023","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/37218682","citation_count":1,"is_preprint":false},{"pmid":"40869285","id":"PMC_40869285","title":"AI-Based Facial Phenotyping Supports a Shared Molecular Axis in PACS1-, PACS2-, and WDR37-Related Syndromes.","date":"2025","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/40869285","citation_count":1,"is_preprint":false},{"pmid":"39911171","id":"PMC_39911171","title":"PACS2, PACS1, and VACTERL: A Clinical Overlap.","date":"2024","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/39911171","citation_count":1,"is_preprint":false},{"pmid":"33994196","id":"PMC_33994196","title":"WITHDRAWN: Schuurs-Hoeijmakers syndrome: Severe expression of the recurrent PACS1 c.607C>T mutation.","date":"2021","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/33994196","citation_count":1,"is_preprint":false},{"pmid":"41279321","id":"PMC_41279321","title":"The Structural Basis for Pacs1-Wdr37 Complex Assembly and Stability.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41279321","citation_count":0,"is_preprint":false},{"pmid":"41888583","id":"PMC_41888583","title":"PACS1 syndrome mutation disrupts dynein-mediated cargo transport via HDAC6 and BICD2.","date":"2026","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/41888583","citation_count":0,"is_preprint":false},{"pmid":"41882293","id":"PMC_41882293","title":"DNA methylation signature and clinical delineation of PACS1-related disorder in 24 unreported individuals.","date":"2026","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/41882293","citation_count":0,"is_preprint":false},{"pmid":"41497635","id":"PMC_41497635","title":"PACS1 syndrome variant alters proteomic landscape of developing cortical organoids.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41497635","citation_count":0,"is_preprint":false},{"pmid":"38712144","id":"PMC_38712144","title":"PACS-1 variant protein is aberrantly localized in C. elegans model of PACS1/PACS2 syndromes.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38712144","citation_count":0,"is_preprint":false},{"pmid":"37747683","id":"PMC_37747683","title":"Genetic characterization of Schuurs-Hoeijmakers syndrome in a moroccan individual with heterozygote PACS1 mutation.","date":"2023","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/37747683","citation_count":0,"is_preprint":false},{"pmid":"41858172","id":"PMC_41858172","title":"The R203W substitution drives PACS-1 syndrome by disrupting intramolecular regulation.","date":"2026","source":"The FEBS journal","url":"https://pubmed.ncbi.nlm.nih.gov/41858172","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.01.662510","title":"The effect of environmental enrichment on immune cell DNA methylation profiles depends on the parity of sows","date":"2025-07-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.01.662510","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.05.24310862","title":"Genotypic and phenotypic analysis of 173 patients with extremely rare pathogenic mutations who applied for experimental antisense oligonucleotide treatment","date":"2024-08-06","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.05.24310862","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.27.24319460","title":"Deleterious coding variation associated with autism is consistent across populations, as exemplified by admixed Latin American populations","date":"2025-01-06","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.27.24319460","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":26321,"output_tokens":7090,"usd":0.092657,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":16030,"output_tokens":4412,"usd":0.095225,"stage2_stop_reason":"end_turn"},"total_usd":0.187882,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"PACS-1 directs TGN localization of furin by binding to the protease's phosphorylated cytosolic (acidic cluster) domain; PACS-1 connects furin to the clathrin-sorting machinery (AP-1) and functions as a coat-like protein mediating endosome-to-TGN retrieval. Antisense knockdown showed that TGN localization of furin and mannose-6-phosphate receptor, but not TGN46, depends strictly on PACS-1.\",\n      \"method\": \"In vitro binding assays, in vivo localization studies, antisense knockdown, cell-free TGN retrieval assays\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — multiple orthogonal in vitro and in vivo methods, foundational study with strong controls\",\n      \"pmids\": [\"9695949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"HIV-1 Nef binds PACS-1 via its acidic cluster (EEEE) motif; this interaction is required for Nef-induced downregulation of cell-surface MHC-I and its relocalization to the TGN. A chimeric protein bearing Nef as cytoplasmic domain localizes to the TGN after internalization in an acidic-cluster- and PACS-1-dependent manner.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PACS-1 expression, chimeric protein localization assays, confocal microscopy\",\n      \"journal\": \"Nature cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal interaction validated by multiple approaches, replicated by subsequent studies\",\n      \"pmids\": [\"10707087\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PACS-1 associates with adaptor complexes AP-1 and AP-3, but not AP-2, forming a ternary complex with furin and AP-1. A short sequence in PACS-1 mediates AP-1 binding; mutation of this motif creates a dominant-negative that mislocalizes furin and mannose-6-phosphate receptor from the TGN and inhibits Nef-mediated MHC-I downregulation.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative mutagenesis, subcellular localization assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal Co-IP, domain mutagenesis, functional rescue experiments\",\n      \"pmids\": [\"11331585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Nef and PACS-1 cooperate to usurp the ARF6 endocytic pathway in a PI3K-dependent manner to downregulate cell-surface MHC-I to the TGN. Three Nef motifs act hierarchically: acidic cluster 62EEEE65 controls PACS-1-dependent TGN sorting, 72PXXP75 controls ARF6 activation, and M20 sequesters internalized MHC-I to the TGN.\",\n      \"method\": \"Dominant-negative expression, ARF6 activation assays, PI3K inhibition, mutagenesis of Nef motifs, subcellular localization\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — mechanistic epistasis with multiple mutants and orthogonal pathway inhibitors\",\n      \"pmids\": [\"12526811\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PACS-1 interacts with the acidic cluster in the cytoplasmic domain of HCMV glycoprotein B (gB) and is required for normal TGN localization of gB. Inhibition of PACS-1 function in infected cells decreases HCMV titer; overexpression of functional PACS-1 increases titer.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PACS-1 expression, viral titer assays, subcellular localization\",\n      \"journal\": \"Journal of virology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, dominant-negative, functional titer readout, single lab with multiple methods\",\n      \"pmids\": [\"14512558\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"PACS-1 mediates phosphorylation-dependent recruitment to VAMP4: CK2 phosphorylation of Ser30 on VAMP4 promotes PACS-1 binding and enhances AP-1 association with VAMP4. Dominant-negative PACS-1 causes mislocalization of VAMP4 in the regulated secretory pathway.\",\n      \"method\": \"Co-immunoprecipitation, mutagenesis of phosphorylation site, dominant-negative PACS-1, subcellular localization in AtT20 cells\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation-site mutagenesis, dominant-negative, Co-IP, functional localization readout\",\n      \"pmids\": [\"14608369\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"CK2-mediated phosphorylation of three critical serine residues within an acidic cluster of nephrocystin promotes PACS-1 binding; this interaction is required for colocalization of nephrocystin with PACS-1 at the base of cilia. CK2 inhibition abolishes the interaction and causes loss of correct nephrocystin targeting.\",\n      \"method\": \"Co-immunoprecipitation, CK2 inhibition, mutagenesis of nephrocystin phosphorylation sites, immunofluorescence colocalization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — phosphorylation-site mutagenesis, kinase inhibition, Co-IP, functional localization readout\",\n      \"pmids\": [\"16308564\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"PACS-1 forms a trimeric complex with GGA3 and CK2 to control CI-MPR sorting. CK2 bound to PACS-1 phosphorylates GGA3, releasing it from CI-MPR, and also phosphorylates PACS-1 Ser278, promoting PACS-1 binding to CI-MPR for retrieval to the TGN. PACS-1 thus links GGA3 to CK2 in a phosphorylation cascade coordinating opposing sorting steps.\",\n      \"method\": \"Co-immunoprecipitation, in vitro kinase assays, mutagenesis of PACS-1 Ser278, GGA3 phosphorylation assays, subcellular localization\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — in vitro kinase assay, reciprocal Co-IP, site-directed mutagenesis, multiple orthogonal methods\",\n      \"pmids\": [\"16977309\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"PACS-1 knockdown (siRNA) has no effect on Nef-induced HLA-A2 downregulation or on localization of other acidic-cluster-containing proteins in HeLa cells, in contrast to AP-1 and clathrin knockdown which do inhibit Nef activity. Immuno-EM shows Nef reroutes MHC-I to endosomes rather than the TGN.\",\n      \"method\": \"siRNA knockdown of PACS-1, AP-1, clathrin; flow cytometry; immuno-electron microscopy\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — negative finding for PACS-1 role in Nef/MHC-I in HeLa cells specifically; single lab contradicting earlier work\",\n      \"pmids\": [\"17581864\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SorLA TGN localization and its activity in retaining APP requires functional interaction with PACS-1 and GGA adaptors. Aberrant targeting of sorLA to the recycling compartment or plasma membrane causes faulty APP trafficking and increased amyloidogenic processing.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative adaptor expression, subcellular localization assays, APP processing readout\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP plus functional APP processing readout, single lab\",\n      \"pmids\": [\"17855360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"PACS-1 mediates CK2 phosphorylation-dependent ciliary trafficking of the olfactory CNG channel. CNGB1b contains PACS-1 binding sites phosphorylated by CK2; PACS-1 interacts with the CNG channel complex, and adenoviral expression of dominant-negative PACS-1 or CK2 inhibition causes CNG channel loss from cilia and olfactory dysfunction.\",\n      \"method\": \"Co-immunoprecipitation, dominant-negative PACS-1 adenoviral expression, CK2 inhibition, electrophysiology (olfactory function), immunofluorescence\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — dominant-negative, Co-IP, CK2 inhibition, functional electrophysiological readout\",\n      \"pmids\": [\"19710307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"A bipartite site on Nef (EEEE65 acidic cluster + W113 in core domain) interacts with a cargo subsite on PACS-1 and PACS-2. This interaction occurs on Rab5- and Rab7-positive endosomes (demonstrated by bimolecular fluorescence complementation). Disruption of the Nef–PACS interaction prevents Nef-induced MHC-I downregulation in PBMCs.\",\n      \"method\": \"Bimolecular fluorescence complementation, mutagenesis of Nef and PACS interaction sites, Co-immunoprecipitation, MHC-I downregulation assay in PBMCs\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods including BiFC for in-cell interaction mapping, functional rescue\",\n      \"pmids\": [\"22496420\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"The PACS1 p.Arg203Trp de novo missense mutation causes PACS-1 to form cytoplasmic aggregates with increased protein stability in vitro. Mutant PACS1 shows impaired binding to a TRPV4 isoform but not the full-length protein. Expression of mutant PACS1 mRNA in zebrafish disrupts cranial (SOX10-positive) neural-crest cell specification and migration, causing craniofacial defects in a dominant-negative fashion.\",\n      \"method\": \"In vitro protein expression/aggregation assays, co-immunoprecipitation with TRPV4 isoforms, zebrafish mRNA injection with SOX10 reporter imaging\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro protein assays, binding assay, in vivo zebrafish model with lineage tracing\",\n      \"pmids\": [\"23159249\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PACS1 interaction with SORLA is required for SORLA/APP complex sorting to the TGN in neurons. PACS1 knockdown or a PACS1-binding-defective SORLA mutant in transgenic mice increases APP processing and Aβ production. PACS1 loss also impairs CI-MPR and cathepsin B expression, affecting Aβ degradation independently of SORLA.\",\n      \"method\": \"siRNA knockdown in neuronal cell lines, transgenic mice with PACS1-binding-defective SORLA mutant, APP processing/Aβ ELISA, CI-MPR and cathepsin B Western blot\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockdown plus transgenic mouse model, multiple functional readouts\",\n      \"pmids\": [\"24001769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PACS-1 protein accumulates in the nucleus during cell cycle progression and interacts with HDAC2 and HDAC3 to regulate chromatin dynamics by maintaining histone acetylation status. PACS-1 knockdown leads to proteasome-mediated degradation of HDAC2/HDAC3, elevated H3K9 and H4K16 acetylation, and increased replication stress-induced DNA damage and genomic instability.\",\n      \"method\": \"Subcellular fractionation/nuclear accumulation during cell cycle, Co-immunoprecipitation of PACS-1 with HDAC2/HDAC3, siRNA knockdown, histone acetylation Western blot, DNA damage assays\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, siRNA, multiple biochemical readouts, single lab\",\n      \"pmids\": [\"31988453\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Par3 facilitates BACE1 retrograde endosome-to-TGN trafficking through aPKC-mediated phosphorylation of BACE1 Ser498, which promotes BACE1 interaction with PACS-1; disruption of this phosphorylation in AD brains correlates with reduced retrograde transport.\",\n      \"method\": \"Co-immunoprecipitation, site-directed mutagenesis of BACE1 Ser498, subcellular localization assays, human AD brain phosphorylation analysis\",\n      \"journal\": \"Neurobiology of aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, phospho-site mutagenesis, localization assay, single lab\",\n      \"pmids\": [\"28946017\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"PCAF and ADA3 transcriptionally regulate PACS1 expression. Cells with decreased PACS1 expression fail to undergo mitochondrial apoptosis (cytochrome c release) in response to granzyme B, staurosporine, UV, and etoposide due to perturbed BAX and BAK oligomerization, placing PACS1 as a required component for intrinsic apoptosis upstream of BAX/BAK oligomerization.\",\n      \"method\": \"siRNA knockdown of PACS1, cytochrome c release assay, BAX/BAK oligomerization native gel assay, cell death assays with multiple stimuli\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — loss-of-function with specific mechanistic readout (BAX/BAK oligomerization), single lab\",\n      \"pmids\": [\"28060382\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PACS1 shuttles between nucleus and cytoplasm, associates with HIV-1 Rev and CRM1, and contributes to nuclear export of unspliced viral RNA. Overexpression of PACS1 increases nuclear export of unspliced viral RNA and p24 in HIV-1-infected CD4+ T cells; siRNA depletion reduces this activity.\",\n      \"method\": \"Nuclear/cytoplasmic fractionation, Co-immunoprecipitation with Rev and CRM1, siRNA knockdown and overexpression, viral RNA export assays, p24 ELISA\",\n      \"journal\": \"Virology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, fractionation, functional overexpression/knockdown in infected cells, single lab\",\n      \"pmids\": [\"31759187\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"PACS-1 and AP-1 are required for targeting of POMC (pro-ACTH) to dense core secretory granules (DCSGs). Knockdown of PACS-1 or AP-1 causes POMC to be secreted into the extracellular milieu rather than packaged into DCSGs.\",\n      \"method\": \"siRNA knockdown, subcellular fractionation, secretion assay\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — siRNA knockdown with defined secretion phenotype, single lab\",\n      \"pmids\": [\"30458990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"PACS-1 nuclear localization occurs at G1-S phase of the cell cycle (detected by immunofluorescence post-serum starvation release). Loss of PACS-1 via siRNA increases nuclear γH2AX and Lys382-p53 acetylation, indicating DNA damage response; PACS-1 re-expression reverses these effects.\",\n      \"method\": \"siRNA knockdown, serum starvation/release cell cycle synchronization, immunofluorescence for γH2AX and p53 acetylation, flow cytometry\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — loss- and gain-of-function with biochemical readouts, single lab\",\n      \"pmids\": [\"33028635\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Pacs1 and Wdr37 form a complex required for normal ER Ca2+ handling in lymphocytes. Pacs1 deletion causes peripheral lymphopenia linked to blunted Ca2+ release from ER after antigen receptor stimulation, diminished IP3 receptor expression, and increased ER and oxidative stress. Mature Pacs1-/- B cells lose quiescence spontaneously, and Pacs1-Wdr37 disruption suppresses lymphoproliferative disease in mouse models.\",\n      \"method\": \"Knockout mouse (Pacs1-/-), Ca2+ imaging, forward genetic screening, IP3 receptor expression analysis, lymphocyte proliferation assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse with multiple functional readouts, Ca2+ imaging, discovery by forward genetic screen\",\n      \"pmids\": [\"33630350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"PACS-1 nuclear-cytoplasmic trafficking is mediated by importin alpha 5 (nuclear import) and exportin 1/CRM1 (nuclear export), defined by an NLS (residues 311–318) and NES3 (residues 366–375). PACS-1 forms a complex with the RNA-binding protein PTBP1 in both nucleus and cytosol; mutation of the NLS or NES3 alters localization of this PACS-1/PTBP1 complex.\",\n      \"method\": \"Mutagenesis of NLS and NES, importin/exportin interaction assays, Co-immunoprecipitation with PTBP1, subcellular localization\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — site-directed mutagenesis of transport signals with functional localization readout, Co-IP, single lab\",\n      \"pmids\": [\"34822171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PACS1 p.R203W mutation increases PACS1 interaction with HDAC6, aberrantly potentiating its deacetylase activity, reducing acetylation of α-tubulin and cortactin, causing Golgi ribbon fragmentation and overpopulation of dendrites. Dendrites show varicosities, diminished spine density, and fewer functional synapses. PACS1- or HDAC6-targeting antisense oligonucleotides, or HDAC6 inhibitors, restore neuronal structure and synaptic transmission in PACS1 syndrome mice and patient NPCs.\",\n      \"method\": \"Co-immunoprecipitation (patient cells and mouse), HDAC6 activity assay, α-tubulin/cortactin acetylation Western blot, Golgi morphology imaging, spine density/synapse electrophysiology, ASO treatment in mice and patient iPSC-derived NPCs\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro activity assay, patient cells, mouse model, multiple orthogonal methods, therapeutic rescue\",\n      \"pmids\": [\"37848409\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"PACS-1 interacts with TRPC3 calcium channel and ESyt1 ER-plasma membrane tethering protein, promotes TRPC3–ESyt1 interactions, and regulates their plasma membrane localization. PACS-1 is required for proper store-operated calcium entry (SOCE) response, and ESyt1 regulates ACTH secretion through a mechanism dependent on PACS-1.\",\n      \"method\": \"Co-immunoprecipitation, plasma membrane localization assays, SOCE calcium imaging, ACTH secretion assay with knockdown\",\n      \"journal\": \"ACS omega\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, functional calcium and hormone secretion readouts, single lab\",\n      \"pmids\": [\"39157130\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structure of the Pacs1–Wdr37 complex shows Pacs1 binds Wdr37 through a conserved interface within its furin-binding region (FBR). This interaction stabilizes Wdr37 and is critical for expression of both proteins. The pathogenic R203W mutation lies on a solvent-exposed surface of the FBR and does not disrupt complex formation. Structural homology of the FBR to synaptotagmin C2 domains reveals Pacs1 can bind negatively charged phospholipids through a positively charged cleft.\",\n      \"method\": \"Cryo-electron microscopy structure determination, biochemical stability assays, phospholipid binding assays, expression analysis of R203W mutant\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — cryo-EM structure with functional validation, structural homology analysis, preprint\",\n      \"pmids\": [\"41279321\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PACS1 interacts with cytoplasmic dynein-1 heavy chain (DHC1) and is required for furin localization at the TGN. PACS1R203W induces a dynein loss-of-function phenotype: PACS1R203W-HDAC6 recruits adaptor BICD2, forming a complex that disperses the Golgi. Cargo motility assays show PACS1R203W reduces dynein initiation frequency and velocity; these defects are rescued by HDAC6 inhibition or Lis1 expression.\",\n      \"method\": \"Co-immunoprecipitation of PACS1 with DHC1 and BICD2, cargo motility assays, HDAC6 inhibition, Lis1 overexpression rescue, Golgi morphology imaging\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, cargo motility assays, genetic/pharmacological rescue, multiple orthogonal methods\",\n      \"pmids\": [\"41888583\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"NMR solution structure of the PACS-1 FBR (residues 101–273) reveals that the PACS-1/HDAC6 interaction is regulated by an intramolecular mechanism: the central unstructured region folds back across the FBR and engages a positively charged extended loop. The R203W substitution, located in this loop, disrupts this regulatory intramolecular interaction and in vitro promotes aberrant protein-protein interactions.\",\n      \"method\": \"NMR structure determination of chimeric FBR, in vitro binding assays with HDAC6, NMR-based interaction mapping, R203W mutagenesis\",\n      \"journal\": \"The FEBS journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — NMR structure with in vitro functional validation and mutagenesis\",\n      \"pmids\": [\"41858172\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PACS-1 is a multifunctional cytosolic adaptor protein whose furin-binding region (FBR) binds phosphorylated acidic cluster motifs on membrane cargo proteins (furin, CI-MPR, BACE1, VAMP4, HCMV gB, HIV-1 Nef, nephrocystin, CNG channel subunit, SorLA) and connects them to clathrin adaptor complexes (AP-1, AP-3) and CK2 to mediate endosome-to-TGN retrieval and ciliary targeting; it forms a structurally defined complex with WDR37 through its FBR (cryo-EM structure), is required for ER Ca²⁺ homeostasis and lymphocyte quiescence, regulates the intrinsic apoptosis pathway via BAX/BAK oligomerization, functions in the nucleus by interacting with HDAC2/HDAC3 to maintain chromatin integrity, and the disease-causing R203W substitution disrupts an intramolecular regulatory interaction in the FBR, aberrantly enhancing HDAC6 deacetylase activity and BICD2-mediated dynein dysfunction to cause Golgi fragmentation and synaptic deficits in neurons.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PACS-1 is a multifunctional cytosolic sorting adaptor that controls the trans-Golgi network (TGN) localization of membrane cargo bearing phosphorylated acidic-cluster motifs [#0]. Its furin-binding region (FBR) recognizes acidic clusters that have been phosphorylated by CK2 on cargo such as furin, the mannose-6-phosphate receptor, VAMP4, nephrocystin, the olfactory CNG channel, SorLA/SORLA, and HCMV glycoprotein B, and it connects these cargo to the clathrin adaptor complexes AP-1 and AP-3 to drive endosome-to-TGN retrieval and ciliary or secretory-granule targeting [#0, #2, #5, #6, #10, #18]. PACS-1 acts as a node in CK2-based phosphorylation cascades, coordinating opposing sorting events by both binding CK2 and being phosphorylated by it (e.g. at Ser278 to control CI-MPR retrieval) [#7]. Through these trafficking functions PACS-1 is exploited by pathogens — HIV-1 Nef engages a cargo subsite on PACS-1 through its acidic cluster to reroute MHC-I [#1, #11] — and modulates neuronal SORLA/APP sorting to limit amyloidogenic processing [#9, #13]. Beyond the secretory pathway, PACS-1 shuttles between nucleus and cytoplasm via importin-α5 and CRM1 [#21], accumulates in the nucleus at G1-S where it stabilizes HDAC2/HDAC3 to maintain histone acetylation and genomic integrity [#14, #19], is required upstream of BAX/BAK oligomerization for intrinsic apoptosis [#16], and forms a complex with WDR37 needed for ER Ca²⁺ homeostasis and lymphocyte quiescence [#20, #24]. The de novo p.R203W substitution in the FBR causes PACS1 syndrome: it disrupts an intramolecular regulatory interaction within the FBR [#26], aberrantly enhancing HDAC6 deacetylase activity to reduce α-tubulin/cortactin acetylation and fragment the Golgi [#22], and promoting a BICD2/dynein loss-of-function that disperses the Golgi and impairs cargo motility, with HDAC6 inhibition or Lis1 rescuing the defects [#25].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established the founding function of PACS-1: how cargo such as furin returns to the TGN was unknown, and PACS-1 was identified as the adaptor that reads phosphorylated acidic clusters and links cargo to clathrin sorting machinery.\",\n      \"evidence\": \"In vitro binding, in vivo localization, antisense knockdown, and cell-free TGN retrieval assays for furin and M6PR\",\n      \"pmids\": [\"9695949\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which clathrin adaptor subunit PACS-1 contacts\", \"Did not resolve the cargo-recognition domain structurally\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Resolved how PACS-1 couples cargo to coats by mapping its association with AP-1 and AP-3 (but not AP-2) and showing a ternary furin–PACS-1–AP-1 complex, establishing the adaptor-bridging logic.\",\n      \"evidence\": \"Co-IP and dominant-negative mutagenesis of the AP-1-binding motif with cargo mislocalization readouts\",\n      \"pmids\": [\"11331585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish stoichiometry or the structural basis of AP-1 engagement\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Showed PACS-1 is not a passive adaptor but a CK2-organized phosphorylation hub, both delivering CK2 to phosphorylate GGA3 and being phosphorylated at Ser278 to coordinate opposing CI-MPR sorting steps.\",\n      \"evidence\": \"In vitro kinase assays, reciprocal Co-IP, and Ser278 mutagenesis with localization readouts\",\n      \"pmids\": [\"16977309\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not generalize the cascade to other cargo\", \"Did not define CK2-binding interface on PACS-1\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Extended PACS-1 cargo-sorting beyond the TGN to ciliary and regulated-secretory targeting, establishing it as a general CK2-phosphorylation-dependent adaptor for acidic-cluster cargo.\",\n      \"evidence\": \"Co-IP, dominant-negative PACS-1, CK2 inhibition, and electrophysiology for CNG channel ciliary trafficking; later siRNA/secretion assays for POMC granule packaging\",\n      \"pmids\": [\"19710307\", \"30458990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish whether ciliary and granule targeting use the same adaptor partners as TGN retrieval\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped the molecular basis of pathogen hijacking by defining a bipartite Nef site engaging a cargo subsite on PACS-1/PACS-2 on Rab5/Rab7 endosomes, refining where and how Nef downregulates MHC-I.\",\n      \"evidence\": \"Bimolecular fluorescence complementation, interaction-site mutagenesis, and MHC-I downregulation assays in PBMCs\",\n      \"pmids\": [\"10707087\", \"22496420\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"A negative siRNA study in HeLa cells (idx 8) indicates the requirement for PACS-1 in Nef/MHC-I is cell-type dependent and not fully reconciled\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Connected PACS-1 trafficking to disease-relevant biology by showing it sorts SORLA/APP to the TGN in neurons, controlling amyloidogenic processing and Aβ degradation.\",\n      \"evidence\": \"siRNA knockdown, transgenic mice with a PACS1-binding-defective SORLA, APP/Aβ ELISA and CI-MPR/cathepsin B blots\",\n      \"pmids\": [\"17855360\", \"24001769\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish a causal role in human Alzheimer's disease\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Revealed unexpected nuclear and apoptotic functions for PACS-1: it stabilizes HDAC2/HDAC3 to maintain chromatin acetylation and genomic integrity, and is required upstream of BAX/BAK oligomerization for intrinsic apoptosis.\",\n      \"evidence\": \"Subcellular fractionation, Co-IP with HDAC2/3, siRNA, histone-acetylation and DNA-damage assays; separate BAX/BAK oligomerization native gels with multiple apoptotic stimuli\",\n      \"pmids\": [\"31988453\", \"28060382\", \"33028635\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab findings without reciprocal structural validation\", \"Mechanism linking cytosolic sorting role to nuclear HDAC stabilization unresolved\", \"How PACS-1 acts upstream of BAX/BAK is undefined\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identified the PACS-1–WDR37 complex as a regulator of ER Ca²⁺ handling and lymphocyte quiescence, and defined the nucleocytoplasmic transport machinery (importin-α5, CRM1) governing PACS-1 shuttling.\",\n      \"evidence\": \"Pacs1-/- knockout mouse with Ca²⁺ imaging and forward genetics; NLS/NES mutagenesis and Co-IP with PTBP1\",\n      \"pmids\": [\"33630350\", \"34822171\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not establish the molecular link between PACS-1/WDR37 and IP3 receptor expression\", \"Functional role of the PACS-1/PTBP1 complex undefined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Defined the mechanism of PACS1 syndrome: the de novo R203W substitution aberrantly enhances HDAC6 deacetylase activity, reducing α-tubulin/cortactin acetylation and fragmenting the Golgi, with HDAC6 inhibition or ASOs rescuing neuronal structure.\",\n      \"evidence\": \"Co-IP from patient cells and mice, HDAC6 activity assays, acetylation blots, synapse electrophysiology, and ASO therapy in mice and patient NPCs\",\n      \"pmids\": [\"23159249\", \"37848409\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve how R203W structurally enables aberrant HDAC6 binding\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Provided the structural and motor-pathway mechanism for the R203W gain-of-function: an intramolecular FBR regulatory interaction is disrupted by R203W, and the mutant couples HDAC6 to BICD2/dynein causing dynein loss-of-function and Golgi dispersal.\",\n      \"evidence\": \"NMR solution structure of the FBR with HDAC6 binding assays; cryo-EM of the Pacs1–Wdr37 complex; Co-IP with DHC1/BICD2, cargo motility assays, HDAC6 inhibition and Lis1 rescue\",\n      \"pmids\": [\"41858172\", \"41888583\", \"41279321\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cryo-EM/phospholipid-binding inference from synaptotagmin homology is from a preprint\", \"How the FBR intramolecular state is normally regulated in cells is undefined\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How PACS-1's diverse functions — cytosolic cargo sorting, nuclear HDAC stabilization, apoptosis, and ER/store-operated Ca²⁺ regulation — are coordinated by one protein, and which are physiologically dominant, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model linking cytosolic and nuclear pools\", \"Relative contribution of trafficking vs HDAC vs dynein defects to PACS1 syndrome unsettled\", \"Structure of full-length PACS-1 with bound cargo unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 2, 5, 7]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [24]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [22, 26]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [0, 21]},\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [0, 22, 25]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [14, 19, 21]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-5653656\", \"supporting_discovery_ids\": [0, 2, 5, 7]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 10, 18]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [14, 19]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [16]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [20]}\n    ],\n    \"complexes\": [\n      \"PACS-1–WDR37 complex\",\n      \"furin–PACS-1–AP-1 ternary complex\",\n      \"PACS-1–GGA3–CK2 trimeric complex\"\n    ],\n    \"partners\": [\n      \"WDR37\",\n      \"AP-1\",\n      \"AP-3\",\n      \"GGA3\",\n      \"HDAC2\",\n      \"HDAC3\",\n      \"HDAC6\",\n      \"BICD2\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}